ARS Pharmaceuticals has entered a licensing agreement with ALK-Abello A/S for the exclusive commercialization of neffy in Europe, Canada, and other regions outside the U.S. ARS Pharma will retain neffy rights in the U.S.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing